Was the DSMB compromised? I saw this post on ya
Post# of 153860
(Total Views: 724)
Posted On: 04/01/2021 12:54:06 AM
Was the DSMB compromised?
I saw this post on yahoo. Your thoughts?
My69zMy69z12 minutes ago
This is sad to even type.
The smoking gun against the FDA's CD12 dosing allowance:
Min 11:45 @ Oct. 20th, 2020 CC.
Can be found in the IR Calendar link on the website:
" As Nader said, there was the DSMC meeting last Thursday
and during the the intro to the meeting, I had asked the members of the committee
to look @ the clinical signals, mortality signals and to specifically address weather we
needed to adjust the dosing. When we had submitted CD10 & CD12, we had proposed
2 doses for the mild to moderate patients, 4 doses for the severe & critical & the FDA
pushed back having to give 2 doses for both study populations. I've never actually been
comfortable with that, and so the question i asked the committee was, was there a signal
that might require Cytodyn to adjust the CD12 dosage. Are there patients who, particularly
critical patients, who might need a 3rd or 4th dose of Leronlimab ?
All his continued comments, have also now been
confirmed. With only 1400 mg's. Wow.
Stunning FDA did not listen to this prominent
doctor, with over 300 studies as the Principal
Investigator.
Notice his comment of --- " was working particularly, in
Severe & Critical "
What incredible results will Severe show??
From being limited to only 2 shots.
His comments make it a fact of needing to
hear from the DSMC & FDA.
Absolutely.
What was DSMC seeing?
Why did the FDA restrict S/C to 2 shots,
with such a safe history pre-Covid?
Most likely the lowest dosage allowed of any trial.
What a sad outcome for this country as of CD12
Critical data is being released.
Not yet even inclusive of the Severe data.
Absolute, smoking gun comments.
My god.
I saw this post on yahoo. Your thoughts?
My69zMy69z12 minutes ago
This is sad to even type.
The smoking gun against the FDA's CD12 dosing allowance:
Min 11:45 @ Oct. 20th, 2020 CC.
Can be found in the IR Calendar link on the website:
" As Nader said, there was the DSMC meeting last Thursday
and during the the intro to the meeting, I had asked the members of the committee
to look @ the clinical signals, mortality signals and to specifically address weather we
needed to adjust the dosing. When we had submitted CD10 & CD12, we had proposed
2 doses for the mild to moderate patients, 4 doses for the severe & critical & the FDA
pushed back having to give 2 doses for both study populations. I've never actually been
comfortable with that, and so the question i asked the committee was, was there a signal
that might require Cytodyn to adjust the CD12 dosage. Are there patients who, particularly
critical patients, who might need a 3rd or 4th dose of Leronlimab ?
All his continued comments, have also now been
confirmed. With only 1400 mg's. Wow.
Stunning FDA did not listen to this prominent
doctor, with over 300 studies as the Principal
Investigator.
Notice his comment of --- " was working particularly, in
Severe & Critical "
What incredible results will Severe show??
From being limited to only 2 shots.
His comments make it a fact of needing to
hear from the DSMC & FDA.
Absolutely.
What was DSMC seeing?
Why did the FDA restrict S/C to 2 shots,
with such a safe history pre-Covid?
Most likely the lowest dosage allowed of any trial.
What a sad outcome for this country as of CD12
Critical data is being released.
Not yet even inclusive of the Severe data.
Absolute, smoking gun comments.
My god.
(20)
(1)